IceCure Medical Ltd.

ICCM Healthcare Medical Devices

IceCure Medical Ltd.’s revenue for fiscal 2025 (year ended December 2025) was $3.4 million, up 2.67% from fiscal 2024. In the quarter to June 2026, revenue was flat, EPS fell 2,068.2%, free cash flow grew 3.88% and total debt fell 64.4%, each against the same quarter a year earlier. Revenue growth for three consecutive years.

1.06 0.02 +1.92%
Market cap
$3.6M
P/E
0.0×
Fwd P/E
−0.2×
Dividend yield
—
F-score
4/9
Altman Z
−10.01
Beneish M
−2.21
Dividend safety
n/a
Older periods Sep '25 Dec '25 Mar '26 Jun '26
Piotroski F-Score

+8 more TTM periods

— — 4 —
ROE
0.00% 0.00% (212.37%) 0.00%
ROA
0.00% 0.00% (126.11%) 0.00%
ROIC
0.00% 0.00% (2,524.58%) 0.00%
Return on Tangible Assets
0.00% 0.00% (185.54%) 0.00%
Average Days of Receivables
0.00 0.00 37.05 0.00
Free Cash Flow per Share
0.00 — (8.48) 0.00
Free Cash Flow
(24.84) — (20.78) (20.63)
Other line items

Show all line items

Columns are period end dates